ライフサイエンスコーパス: blood-borne pathogen

1 the priming of splenic T-cell responses to a blood-borne pathogen.

2 ercent of men tested positive for at least 1 blood-borne pathogen.

3 B cells, providing early immune responses to blood-borne pathogens.

4 ons requiring rapid and reliable testing for blood-borne pathogens.

5 sk for allergic reactions and infection with blood-borne pathogens.

6 ific procedure days were offered testing for blood-borne pathogens.

7 hus restricting their capacity to respond to blood-borne pathogens.

8 role of the complement system in response to blood-borne pathogens.

9 ) (P < 0.01) were most often associated with blood-borne pathogens.

10 mature B cell subset that rapidly respond to blood-borne pathogens.

11 ted and implemented to protect surgeons from blood-borne pathogens.

12 potentially interfering substances or other blood-borne pathogens.

13 ut concerns remain regarding transmission of blood-borne pathogens.

14 ow a very high potential for transmission of blood-borne pathogens.

15 ompartments plays a central role in clearing blood-borne pathogens.

16 e world's largest iatrogenic transmission of blood-borne pathogens.

17 ide a safety advantage in terms of risk from blood-borne pathogens.

18 Therefore, they are at risk of exposure to blood-borne pathogens.

19 in the treatment of diseases associated with blood-borne pathogens.

20 independent humoral immune responses against blood-borne pathogens.

21 system is recognised as a protector against blood-borne pathogens and a controller of immune system

22 leen is an important site for the capture of blood-borne pathogens and a gateway for lymphocytes ente

23 een play an important role in the capture of blood-borne pathogens and are viewed as an essential com

24 using severe malaria syndromes as well other blood-borne pathogens and blood-related diseases.

25 an aberrant MZ that may affect responses to blood-borne pathogens and peripheral B-cell tolerance.

26 idly generate Ag-specific IgM in response to blood-borne pathogens and play an important role in the

27 ism and the phagocytosis of erythrocytes and blood-borne pathogens are significantly reduced prior to

28 o facilitate the safe and rapid clearance of blood-borne pathogens as a potential treatment for infec

29 thelium is the first line of defense against blood-borne pathogens, but it is unclear which NLRs cont

30 ining the risk of iatrogenic transmission of blood-borne pathogens by less invasive routes, such as s

31 The spread of blood-borne pathogens by mosquitoes relies on their taki

32 Meningitis occurs when blood-borne pathogens cross the blood-brain barrier (BBB

33 tutes an interesting approach to investigate blood-borne pathogen diversity in wild vertebrates and c

34 3 to 4 days, and are critical for preventing blood-borne pathogens from evolving into life-threatenin

35 timal timing of live donor testing for these blood borne pathogens has not been determined.

36 tis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of co

37 es have hampered the identification of novel blood-borne pathogens in these animals.

38 d in mounting rapid immune responses against blood-borne pathogens, including conventional dendritic

39 require the rapid and accurate detection of blood-borne pathogens, including human immunodeficiency

40 While the incidence of these blood-borne pathogens is increasing in the general popul

41 Hepatitis C virus (HCV) is a blood borne pathogen mostly transmitted via percutaneous

42 nsidered to be important for TI responses to blood-borne pathogens, MZ B cells were not responsible f

43 y, 380 000-400 000 occupational exposures to blood-borne pathogens occur annually in the United State

44 rne Zika virus (ZIKV) is now recognized as a blood-borne pathogen, raising an important question abou

45 ings, risks of occupational infection with 3 blood-borne pathogens remain in the health care workplac

46 nfected fibrin clot-and show that the common blood-borne pathogen Staphylococcus epidermidis influenc

47 say for the multiplexed identification of 20 blood-borne pathogens (Staphylococcus epidermidis, Staph

48 number of recipients becoming infected with blood-borne pathogens such as HIV and hepatitis C.

49 luding the respiratory virus SARS-CoV-2, and blood-borne pathogens such as HIV, HBV and HCV as clinic

50 Hepatitis B virus (HBV) is an important blood-borne pathogen that causes hepatic inflammation an

51 Hepatitis C virus (HCV) is a common blood-borne pathogen that relies heavily on nucleic acid

52 erences in transmission of the 3 most common blood-borne pathogens, the natural history of early HCV

53 re part of the first line of defense against blood-borne pathogens, their increase following a breach

54 th fenestrations that can potentially permit blood-borne pathogens to access the brain(2).

55 prevention by creating a program to prevent blood-borne pathogen transmission; by encouraging infect

56 Testing for blood-borne pathogens was performed in 53% (N = 373) of

57 es execute vaccine-elicited immunity against blood-borne pathogens, we found that invasive bacteria a

58 Blood-borne pathogens were diagnosed by polymerase chain

59 operations (142/373) were found to involve a blood-borne pathogen when tested: HIV (26%), hepatitis B

60 ify, in a multiplexed fashion, a panel of 20 blood-borne pathogens with high sensitivity and specific